VERTEX PHARMACEUTICALS INC (VRTX)       319.98  -1.47 (-0.46%)

319.98  -1.47 (-0.46%)

US92532F1003 - Common Stock - After market: 319.99 0.01 (0%)

EPS Estimates (USD)

Recent Earnings VS Estimates
Period Reported Estimate Difference Surprise Q3 2022 4.01 3.72 0.297.89% Q2 2022 3.60 3.55 0.051.44% Q1 2022 3.52 3.56 -0.04-1.18% Q4 2021 3.37 3.37 0.000.13% Q3 2021 3.56 3.14 0.4213.27% Q2 2021 3.11 2.56 0.5521.59% Q1 2021 2.98 2.74 0.248.66% Q4 2020 2.51 2.64 -0.13-5.00%
Future EPS Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 14.94 13.02 14.77%Q4 2022 3.63 3.37 7.72%FY 2023 16.14 14.94 8.04%Q1 2023 3.90 3.52 10.90%Q2 2023 3.98 3.60 10.68%Q3 2023 4.09 4.01 2.07%Q4 2023 4.16 3.63 14.53%FY 2024 17.25 16.14 6.83%FY 2025 18.50 17.25 7.25%FY 2026 19.95 18.50 7.87%FY 2027 21.56 19.95 8.05%FY 2028 22.01 21.56 2.08%FY 2029 23.21 22.01 5.46%FY 2030 24.44 23.21 5.32%

Revenue Estimates (USD)

Recent Revenue VS Estimates
Period Reported Estimate Difference Surprise Q3 2022 2.334B 2.271B 63.3M2.79% Q2 2022 2.196B 2.175B 21.2M0.97% Q1 2022 2.098B 2.118B -20.5M-0.97% Q4 2021 2.073B 2.043B 29.561M1.45% Q3 2021 1.984B 1.893B 91.164M4.82% Q2 2021 1.793B 1.752B 41.37M2.36% Q1 2021 1.724B 1.69B 34.3M2.03% Q4 2020 1.628B 1.616B 11.8M0.73%
Future Revenue Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 9.105B 7.574B 20.21%Q4 2022 2.346B 2.073B 13.19%FY 2023 9.756B 9.105B 7.15%Q1 2023 2.348B 2.098B 11.94%Q2 2023 2.413B 2.196B 9.87%Q3 2023 2.465B 2.334B 5.60%Q4 2023 2.533B 2.346B 7.97%FY 2024 10.421B 9.756B 6.82%FY 2025 11.04B 10.421B 5.94%FY 2026 11.691B 11.04B 5.90%FY 2027 12.104B 11.691B 3.53%FY 2028 12.605B 12.104B 4.14%FY 2029 12.994B 12.605B 3.09%FY 2030 13.45B 12.994B 3.51%